#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0038] A number of techniques for synthesizing polypeptide or peptide-linked molecules in vitro have been described.
1-1	0-1	[	_	_	
1-2	1-5	0038	_	_	
1-3	5-6	]	_	_	
1-4	7-8	A	_	_	
1-5	9-15	number	_	_	
1-6	16-18	of	_	_	
1-7	19-29	techniques	_	_	
1-8	30-33	for	_	_	
1-9	34-46	synthesizing	_	_	
1-10	47-58	polypeptide	_	_	
1-11	59-61	or	_	_	
1-12	62-76	peptide-linked	_	_	
1-13	77-86	molecules	_	_	
1-14	87-89	in	_	_	
1-15	90-95	vitro	_	_	
1-16	96-100	have	_	_	
1-17	101-105	been	_	_	
1-18	106-115	described	_	_	
1-19	115-116	.	_	_	

#Text=For example, stepwise blocking/de-blocking methods have been known in the art for many years as a way of building polypeptide molecules.
2-1	117-120	For	_	_	
2-2	121-128	example	_	_	
2-3	128-129	,	_	_	
2-4	130-138	stepwise	_	_	
2-5	139-147	blocking	_	_	
2-6	147-148	/	_	_	
2-7	148-159	de-blocking	_	_	
2-8	160-167	methods	_	_	
2-9	168-172	have	_	_	
2-10	173-177	been	_	_	
2-11	178-183	known	_	_	
2-12	184-186	in	_	_	
2-13	187-190	the	_	_	
2-14	191-194	art	_	_	
2-15	195-198	for	_	_	
2-16	199-203	many	_	_	
2-17	204-209	years	_	_	
2-18	210-212	as	_	_	
2-19	213-214	a	_	_	
2-20	215-218	way	_	_	
2-21	219-221	of	_	_	
2-22	222-230	building	_	_	
2-23	231-242	polypeptide	_	_	
2-24	243-252	molecules	_	_	
2-25	252-253	.	_	_	

#Text=However, these methods generally require multiple chemical steps for the addition of each amino acid to the polymer resulting in a time-consuming process with a low product yield.
#Text=[0039] An alternative, solution-based approach to synthesizing a peptide molecule may be achieved using a carbodiimide method.
3-1	254-261	However	_	_	
3-2	261-262	,	_	_	
3-3	263-268	these	_	_	
3-4	269-276	methods	_	_	
3-5	277-286	generally	_	_	
3-6	287-294	require	_	_	
3-7	295-303	multiple	_	_	
3-8	304-312	chemical	_	_	
3-9	313-318	steps	_	_	
3-10	319-322	for	_	_	
3-11	323-326	the	_	_	
3-12	327-335	addition	_	_	
3-13	336-338	of	_	_	
3-14	339-343	each	_	_	
3-15	344-349	amino	_	_	
3-16	350-354	acid	_	_	
3-17	355-357	to	_	_	
3-18	358-361	the	_	_	
3-19	362-369	polymer	_	_	
3-20	370-379	resulting	_	_	
3-21	380-382	in	_	_	
3-22	383-384	a	_	_	
3-23	385-399	time-consuming	_	_	
3-24	400-407	process	_	_	
3-25	408-412	with	_	_	
3-26	413-414	a	_	_	
3-27	415-418	low	_	_	
3-28	419-426	product	_	_	
3-29	427-432	yield	_	_	
3-30	432-433	.	_	_	
3-31	434-435	[	_	_	
3-32	435-439	0039	_	_	
3-33	439-440	]	_	_	
3-34	441-443	An	_	_	
3-35	444-455	alternative	_	_	
3-36	455-456	,	_	_	
3-37	457-471	solution-based	_	_	
3-38	472-480	approach	_	_	
3-39	481-483	to	_	_	
3-40	484-496	synthesizing	_	_	
3-41	497-498	a	_	_	
3-42	499-506	peptide	_	_	
3-43	507-515	molecule	_	_	
3-44	516-519	may	_	_	
3-45	520-522	be	_	_	
3-46	523-531	achieved	_	_	
3-47	532-537	using	_	_	
3-48	538-539	a	*[1]	5-1[2_1]	
3-49	540-552	carbodiimide	*[1]	_	
3-50	553-559	method	*[1]	_	
3-51	559-560	.	_	_	

#Text=This approach generally relies on the use of a carbodiimide molecule (e.g., dicyclohexylcarbodiimide (DCC), etc.) to activate a carboxyl (e.g., --COOH) group of one compound, such as an amino acid, to produce a highly reactive intermediate which may then react and bond to other compounds or molecules, such as through an amino group of an amino acid to form a peptide bond.
4-1	561-565	This	_	_	
4-2	566-574	approach	_	_	
4-3	575-584	generally	_	_	
4-4	585-591	relies	_	_	
4-5	592-594	on	_	_	
4-6	595-598	the	_	_	
4-7	599-602	use	_	_	
4-8	603-605	of	_	_	
4-9	606-607	a	_	_	
4-10	608-620	carbodiimide	_	_	
4-11	621-629	molecule	_	_	
4-12	630-631	(	_	_	
4-13	631-634	e.g	_	_	
4-14	634-635	.	_	_	
4-15	635-636	,	_	_	
4-16	637-661	dicyclohexylcarbodiimide	_	_	
4-17	662-663	(	_	_	
4-18	663-666	DCC	_	_	
4-19	666-667	)	_	_	
4-20	667-668	,	_	_	
4-21	669-672	etc	_	_	
4-22	672-673	.	_	_	
4-23	673-674	)	_	_	
4-24	675-677	to	_	_	
4-25	678-686	activate	_	_	
4-26	687-688	a	_	_	
4-27	689-697	carboxyl	_	_	
4-28	698-699	(	_	_	
4-29	699-702	e.g	_	_	
4-30	702-703	.	_	_	
4-31	703-704	,	_	_	
4-32	705-706	-	_	_	
4-33	706-707	-	_	_	
4-34	707-711	COOH	_	_	
4-35	711-712	)	_	_	
4-36	713-718	group	_	_	
4-37	719-721	of	_	_	
4-38	722-725	one	_	_	
4-39	726-734	compound	_	_	
4-40	734-735	,	_	_	
4-41	736-740	such	_	_	
4-42	741-743	as	_	_	
4-43	744-746	an	_	_	
4-44	747-752	amino	_	_	
4-45	753-757	acid	_	_	
4-46	757-758	,	_	_	
4-47	759-761	to	_	_	
4-48	762-769	produce	_	_	
4-49	770-771	a	_	_	
4-50	772-778	highly	_	_	
4-51	779-787	reactive	_	_	
4-52	788-800	intermediate	_	_	
4-53	801-806	which	_	_	
4-54	807-810	may	_	_	
4-55	811-815	then	_	_	
4-56	816-821	react	_	_	
4-57	822-825	and	_	_	
4-58	826-830	bond	_	_	
4-59	831-833	to	_	_	
4-60	834-839	other	_	_	
4-61	840-849	compounds	_	_	
4-62	850-852	or	_	_	
4-63	853-862	molecules	_	_	
4-64	862-863	,	_	_	
4-65	864-868	such	_	_	
4-66	869-871	as	_	_	
4-67	872-879	through	_	_	
4-68	880-882	an	_	_	
4-69	883-888	amino	_	_	
4-70	889-894	group	_	_	
4-71	895-897	of	_	_	
4-72	898-900	an	_	_	
4-73	901-906	amino	_	_	
4-74	907-911	acid	_	_	
4-75	912-914	to	_	_	
4-76	915-919	form	_	_	
4-77	920-921	a	_	_	
4-78	922-929	peptide	_	_	
4-79	930-934	bond	_	_	
4-80	934-935	.	_	_	

#Text=This method may be used to link two amino acids together or to couple an amino acid (or preformed peptide) to an active agent.
5-1	936-940	This	*[2]	_	
5-2	941-947	method	*[2]	_	
5-3	948-951	may	_	_	
5-4	952-954	be	_	_	
5-5	955-959	used	_	_	
5-6	960-962	to	_	_	
5-7	963-967	link	_	_	
5-8	968-971	two	_	_	
5-9	972-977	amino	_	_	
5-10	978-983	acids	_	_	
5-11	984-992	together	_	_	
5-12	993-995	or	_	_	
5-13	996-998	to	_	_	
5-14	999-1005	couple	_	_	
5-15	1006-1008	an	_	_	
5-16	1009-1014	amino	_	_	
5-17	1015-1019	acid	_	_	
5-18	1020-1021	(	_	_	
5-19	1021-1023	or	_	_	
5-20	1024-1033	preformed	_	_	
5-21	1034-1041	peptide	_	_	
5-22	1041-1042	)	_	_	
5-23	1043-1045	to	_	_	
5-24	1046-1048	an	_	_	
5-25	1049-1055	active	_	_	
5-26	1056-1061	agent	_	_	
5-27	1061-1062	.	_	_	

#Text=However, this carbodiimide reaction scheme is not capable of self-polymerization and merely provides a coupling or linking mechanism for joining two molecules.
6-1	1063-1070	However	_	_	
6-2	1070-1071	,	_	_	
6-3	1072-1076	this	_	_	
6-4	1077-1089	carbodiimide	_	_	
6-5	1090-1098	reaction	_	_	
6-6	1099-1105	scheme	_	_	
6-7	1106-1108	is	_	_	
6-8	1109-1112	not	_	_	
6-9	1113-1120	capable	_	_	
6-10	1121-1123	of	_	_	
6-11	1124-1143	self-polymerization	_	_	
6-12	1144-1147	and	_	_	
6-13	1148-1154	merely	_	_	
6-14	1155-1163	provides	_	_	
6-15	1164-1165	a	_	_	
6-16	1166-1174	coupling	_	_	
6-17	1175-1177	or	_	_	
6-18	1178-1185	linking	_	_	
6-19	1186-1195	mechanism	_	_	
6-20	1196-1199	for	_	_	
6-21	1200-1207	joining	_	_	
6-22	1208-1211	two	_	_	
6-23	1212-1221	molecules	_	_	
6-24	1221-1222	.	_	_	

#Text=Once a carbodiimide-activated molecule, such as a carbodiimide-activated amino acid, is allowed to react with another compound, the reaction is complete.
7-1	1223-1227	Once	_	_	
7-2	1228-1229	a	_	_	
7-3	1230-1252	carbodiimide-activated	_	_	
7-4	1253-1261	molecule	_	_	
7-5	1261-1262	,	_	_	
7-6	1263-1267	such	_	_	
7-7	1268-1270	as	_	_	
7-8	1271-1272	a	_	_	
7-9	1273-1295	carbodiimide-activated	_	_	
7-10	1296-1301	amino	_	_	
7-11	1302-1306	acid	_	_	
7-12	1306-1307	,	_	_	
7-13	1308-1310	is	_	_	
7-14	1311-1318	allowed	_	_	
7-15	1319-1321	to	_	_	
7-16	1322-1327	react	_	_	
7-17	1328-1332	with	_	_	
7-18	1333-1340	another	_	_	
7-19	1341-1349	compound	_	_	
7-20	1349-1350	,	_	_	
7-21	1351-1354	the	_	_	
7-22	1355-1363	reaction	_	_	
7-23	1364-1366	is	_	_	
7-24	1367-1375	complete	_	_	
7-25	1375-1376	.	_	_	

#Text=To synthesize a polypeptide containing, for example, three or more amino acids using the carbodiimide method, a stepwise approach would be necessary to carry out repeated rounds of activation and coupling.
8-1	1377-1379	To	_	_	
8-2	1380-1390	synthesize	_	_	
8-3	1391-1392	a	_	_	
8-4	1393-1404	polypeptide	_	_	
8-5	1405-1415	containing	_	_	
8-6	1415-1416	,	_	_	
8-7	1417-1420	for	_	_	
8-8	1421-1428	example	_	_	
8-9	1428-1429	,	_	_	
8-10	1430-1435	three	_	_	
8-11	1436-1438	or	_	_	
8-12	1439-1443	more	_	_	
8-13	1444-1449	amino	_	_	
8-14	1450-1455	acids	_	_	
8-15	1456-1461	using	_	_	
8-16	1462-1465	the	_	_	
8-17	1466-1478	carbodiimide	_	_	
8-18	1479-1485	method	_	_	
8-19	1485-1486	,	_	_	
8-20	1487-1488	a	_	_	
8-21	1489-1497	stepwise	_	_	
8-22	1498-1506	approach	_	_	
8-23	1507-1512	would	_	_	
8-24	1513-1515	be	_	_	
8-25	1516-1525	necessary	_	_	
8-26	1526-1528	to	_	_	
8-27	1529-1534	carry	_	_	
8-28	1535-1538	out	_	_	
8-29	1539-1547	repeated	_	_	
8-30	1548-1554	rounds	_	_	
8-31	1555-1557	of	_	_	
8-32	1558-1568	activation	_	_	
8-33	1569-1572	and	_	_	
8-34	1573-1581	coupling	_	_	
8-35	1581-1582	.	_	_	

#Text=Such a step-wise approach is a time-consuming process having a substantial reduction in yield to carry out these multiple reaction steps.
9-1	1583-1587	Such	_	_	
9-2	1588-1589	a	_	_	
9-3	1590-1599	step-wise	_	_	
9-4	1600-1608	approach	_	_	
9-5	1609-1611	is	_	_	
9-6	1612-1613	a	_	_	
9-7	1614-1628	time-consuming	_	_	
9-8	1629-1636	process	_	_	
9-9	1637-1643	having	_	_	
9-10	1644-1645	a	_	_	
9-11	1646-1657	substantial	_	_	
9-12	1658-1667	reduction	_	_	
9-13	1668-1670	in	_	_	
9-14	1671-1676	yield	_	_	
9-15	1677-1679	to	_	_	
9-16	1680-1685	carry	_	_	
9-17	1686-1689	out	_	_	
9-18	1690-1695	these	_	_	
9-19	1696-1704	multiple	_	_	
9-20	1705-1713	reaction	_	_	
9-21	1714-1719	steps	_	_	
9-22	1719-1720	.	_	_	

#Text=Furthermore, any additional side groups which might react with a carbodiimide-activated intermediate may need to be blocked to avoid formation of unintended and undesired by-products.
10-1	1721-1732	Furthermore	_	_	
10-2	1732-1733	,	_	_	
10-3	1734-1737	any	_	_	
10-4	1738-1748	additional	_	_	
10-5	1749-1753	side	_	_	
10-6	1754-1760	groups	_	_	
10-7	1761-1766	which	_	_	
10-8	1767-1772	might	_	_	
10-9	1773-1778	react	_	_	
10-10	1779-1783	with	_	_	
10-11	1784-1785	a	_	_	
10-12	1786-1808	carbodiimide-activated	_	_	
10-13	1809-1821	intermediate	_	_	
10-14	1822-1825	may	_	_	
10-15	1826-1830	need	_	_	
10-16	1831-1833	to	_	_	
10-17	1834-1836	be	_	_	
10-18	1837-1844	blocked	_	_	
10-19	1845-1847	to	_	_	
10-20	1848-1853	avoid	_	_	
10-21	1854-1863	formation	_	_	
10-22	1864-1866	of	_	_	
10-23	1867-1877	unintended	_	_	
10-24	1878-1881	and	_	_	
10-25	1882-1891	undesired	_	_	
10-26	1892-1903	by-products	_	_	
10-27	1903-1904	.	_	_	

#Text=In addition, carbodiimides tend to form racemic mixtures of amino acids which may be incorporated into peptide-linked molecules or polymers.
11-1	1905-1907	In	_	_	
11-2	1908-1916	addition	_	_	
11-3	1916-1917	,	_	_	
11-4	1918-1931	carbodiimides	_	_	
11-5	1932-1936	tend	_	_	
11-6	1937-1939	to	_	_	
11-7	1940-1944	form	_	_	
11-8	1945-1952	racemic	_	_	
11-9	1953-1961	mixtures	_	_	
11-10	1962-1964	of	_	_	
11-11	1965-1970	amino	_	_	
11-12	1971-1976	acids	_	_	
11-13	1977-1982	which	_	_	
11-14	1983-1986	may	_	_	
11-15	1987-1989	be	_	_	
11-16	1990-2002	incorporated	_	_	
11-17	2003-2007	into	_	_	
11-18	2008-2022	peptide-linked	_	_	
11-19	2023-2032	molecules	_	_	
11-20	2033-2035	or	_	_	
11-21	2036-2044	polymers	_	_	
11-22	2044-2045	.	_	_	

#Text=Considering that most naturally occurring amino acids are L-amino acids, racemization may make enzyme digestion of carbodiimide-produced polypeptides difficult or impossible, and a large proportion of active agents incorporated into carbodiimide-produced polypeptides or amino acid conjugates may be rendered inaccessible or biologically inactive.
12-1	2046-2057	Considering	_	_	
12-2	2058-2062	that	_	_	
12-3	2063-2067	most	_	_	
12-4	2068-2077	naturally	_	_	
12-5	2078-2087	occurring	_	_	
12-6	2088-2093	amino	_	_	
12-7	2094-2099	acids	_	_	
12-8	2100-2103	are	_	_	
12-9	2104-2111	L-amino	_	_	
12-10	2112-2117	acids	_	_	
12-11	2117-2118	,	_	_	
12-12	2119-2131	racemization	_	_	
12-13	2132-2135	may	_	_	
12-14	2136-2140	make	_	_	
12-15	2141-2147	enzyme	_	_	
12-16	2148-2157	digestion	_	_	
12-17	2158-2160	of	_	_	
12-18	2161-2182	carbodiimide-produced	_	_	
12-19	2183-2195	polypeptides	_	_	
12-20	2196-2205	difficult	_	_	
12-21	2206-2208	or	_	_	
12-22	2209-2219	impossible	_	_	
12-23	2219-2220	,	_	_	
12-24	2221-2224	and	_	_	
12-25	2225-2226	a	_	_	
12-26	2227-2232	large	_	_	
12-27	2233-2243	proportion	_	_	
12-28	2244-2246	of	_	_	
12-29	2247-2253	active	_	_	
12-30	2254-2260	agents	_	_	
12-31	2261-2273	incorporated	_	_	
12-32	2274-2278	into	_	_	
12-33	2279-2300	carbodiimide-produced	_	_	
12-34	2301-2313	polypeptides	_	_	
12-35	2314-2316	or	_	_	
12-36	2317-2322	amino	_	_	
12-37	2323-2327	acid	_	_	
12-38	2328-2338	conjugates	_	_	
12-39	2339-2342	may	_	_	
12-40	2343-2345	be	_	_	
12-41	2346-2354	rendered	_	_	
12-42	2355-2367	inaccessible	_	_	
12-43	2368-2370	or	_	_	
12-44	2371-2383	biologically	_	_	
12-45	2384-2392	inactive	_	_	
12-46	2392-2393	.	_	_	

#Text=Although the addition of triazolol compounds (e.g., hydroxybenzotriazole (HOBt), etc.) have reduced this racemic effect, carbodiimide-based methods remain a less practical approach for synthesizing polypeptide molecules.
#Text=[0040] One effective method for synthesizing polypeptides or peptide-linked polymers that overcomes issues of racemization and non-spontaneous polymerization is the Fuchs-Farthing approach of generating highly reactive N-carboxyanhydride (NCA) intermediates of compounds or amino acids.
13-1	2394-2402	Although	_	_	
13-2	2403-2406	the	_	_	
13-3	2407-2415	addition	_	_	
13-4	2416-2418	of	_	_	
13-5	2419-2428	triazolol	_	_	
13-6	2429-2438	compounds	_	_	
13-7	2439-2440	(	_	_	
13-8	2440-2443	e.g	_	_	
13-9	2443-2444	.	_	_	
13-10	2444-2445	,	_	_	
13-11	2446-2466	hydroxybenzotriazole	_	_	
13-12	2467-2468	(	_	_	
13-13	2468-2472	HOBt	_	_	
13-14	2472-2473	)	_	_	
13-15	2473-2474	,	_	_	
13-16	2475-2478	etc	_	_	
13-17	2478-2479	.	_	_	
13-18	2479-2480	)	_	_	
13-19	2481-2485	have	_	_	
13-20	2486-2493	reduced	_	_	
13-21	2494-2498	this	_	_	
13-22	2499-2506	racemic	_	_	
13-23	2507-2513	effect	_	_	
13-24	2513-2514	,	_	_	
13-25	2515-2533	carbodiimide-based	_	_	
13-26	2534-2541	methods	_	_	
13-27	2542-2548	remain	_	_	
13-28	2549-2550	a	_	_	
13-29	2551-2555	less	_	_	
13-30	2556-2565	practical	_	_	
13-31	2566-2574	approach	_	_	
13-32	2575-2578	for	_	_	
13-33	2579-2591	synthesizing	_	_	
13-34	2592-2603	polypeptide	_	_	
13-35	2604-2613	molecules	_	_	
13-36	2613-2614	.	_	_	
13-37	2615-2616	[	_	_	
13-38	2616-2620	0040	_	_	
13-39	2620-2621	]	_	_	
13-40	2622-2625	One	_	_	
13-41	2626-2635	effective	_	_	
13-42	2636-2642	method	_	_	
13-43	2643-2646	for	_	_	
13-44	2647-2659	synthesizing	_	_	
13-45	2660-2672	polypeptides	_	_	
13-46	2673-2675	or	_	_	
13-47	2676-2690	peptide-linked	_	_	
13-48	2691-2699	polymers	_	_	
13-49	2700-2704	that	_	_	
13-50	2705-2714	overcomes	_	_	
13-51	2715-2721	issues	_	_	
13-52	2722-2724	of	_	_	
13-53	2725-2737	racemization	_	_	
13-54	2738-2741	and	_	_	
13-55	2742-2757	non-spontaneous	_	_	
13-56	2758-2772	polymerization	_	_	
13-57	2773-2775	is	_	_	
13-58	2776-2779	the	_	_	
13-59	2780-2794	Fuchs-Farthing	_	_	
13-60	2795-2803	approach	_	_	
13-61	2804-2806	of	_	_	
13-62	2807-2817	generating	_	_	
13-63	2818-2824	highly	_	_	
13-64	2825-2833	reactive	_	_	
13-65	2834-2852	N-carboxyanhydride	_	_	
13-66	2853-2854	(	_	_	
13-67	2854-2857	NCA	_	_	
13-68	2857-2858	)	_	_	
13-69	2859-2872	intermediates	_	_	
13-70	2873-2875	of	_	_	
13-71	2876-2885	compounds	_	_	
13-72	2886-2888	or	_	_	
13-73	2889-2894	amino	_	_	
13-74	2895-2900	acids	_	_	
13-75	2900-2901	.	_	_	

#Text=Unlike the carbodiimide approach discussed above, this NCA-based method preserves the stereoisomeric state of compounds or amino acids incorporated into a growing polypeptide or polymer chain, i.e., such NCA-based methods are stereospecific.
14-1	2902-2908	Unlike	_	_	
14-2	2909-2912	the	_	_	
14-3	2913-2925	carbodiimide	_	_	
14-4	2926-2934	approach	_	_	
14-5	2935-2944	discussed	_	_	
14-6	2945-2950	above	_	_	
14-7	2950-2951	,	_	_	
14-8	2952-2956	this	_	_	
14-9	2957-2966	NCA-based	*[3]	15-6[4_3]	
14-10	2967-2973	method	*[3]	_	
14-11	2974-2983	preserves	_	_	
14-12	2984-2987	the	_	_	
14-13	2988-3002	stereoisomeric	_	_	
14-14	3003-3008	state	_	_	
14-15	3009-3011	of	_	_	
14-16	3012-3021	compounds	_	_	
14-17	3022-3024	or	_	_	
14-18	3025-3030	amino	_	_	
14-19	3031-3036	acids	_	_	
14-20	3037-3049	incorporated	_	_	
14-21	3050-3054	into	_	_	
14-22	3055-3056	a	_	_	
14-23	3057-3064	growing	_	_	
14-24	3065-3076	polypeptide	_	_	
14-25	3077-3079	or	_	_	
14-26	3080-3087	polymer	_	_	
14-27	3088-3093	chain	_	_	
14-28	3093-3094	,	_	_	
14-29	3095-3098	i.e	_	_	
14-30	3098-3099	.	_	_	
14-31	3099-3100	,	_	_	
14-32	3101-3105	such	_	_	
14-33	3106-3115	NCA-based	_	_	
14-34	3116-3123	methods	_	_	
14-35	3124-3127	are	_	_	
14-36	3128-3142	stereospecific	_	_	
14-37	3142-3143	.	_	_	

#Text=Thus, products formed by this method will have normal peptide bonds which may be recognized and hydrolyzed by, for example, proteases, as well as other natural enzymes.
#Text=[0041] In general, NCA-based methods for synthesizing polymers, such as polypeptides, peptide-linked compounds, etc., may involve two basic reactions: (1) formation of one or more NCA-containing monomer(s) from one or more types of monomer(s), and (2) polymerization of these monomer(s) to form a desired polymer product(s) upon introduction of at least one type of initiator.
15-1	3144-3148	Thus	_	_	
15-2	3148-3149	,	_	_	
15-3	3150-3158	products	_	_	
15-4	3159-3165	formed	_	_	
15-5	3166-3168	by	_	_	
15-6	3169-3173	this	*[4]	_	
15-7	3174-3180	method	*[4]	_	
15-8	3181-3185	will	_	_	
15-9	3186-3190	have	_	_	
15-10	3191-3197	normal	_	_	
15-11	3198-3205	peptide	_	_	
15-12	3206-3211	bonds	_	_	
15-13	3212-3217	which	_	_	
15-14	3218-3221	may	_	_	
15-15	3222-3224	be	_	_	
15-16	3225-3235	recognized	_	_	
15-17	3236-3239	and	_	_	
15-18	3240-3250	hydrolyzed	_	_	
15-19	3251-3253	by	_	_	
15-20	3253-3254	,	_	_	
15-21	3255-3258	for	_	_	
15-22	3259-3266	example	_	_	
15-23	3266-3267	,	_	_	
15-24	3268-3277	proteases	_	_	
15-25	3277-3278	,	_	_	
15-26	3279-3281	as	_	_	
15-27	3282-3286	well	_	_	
15-28	3287-3289	as	_	_	
15-29	3290-3295	other	_	_	
15-30	3296-3303	natural	_	_	
15-31	3304-3311	enzymes	_	_	
15-32	3311-3312	.	_	_	
15-33	3313-3314	[	_	_	
15-34	3314-3318	0041	_	_	
15-35	3318-3319	]	_	_	
15-36	3320-3322	In	_	_	
15-37	3323-3330	general	_	_	
15-38	3330-3331	,	_	_	
15-39	3332-3341	NCA-based	_	_	
15-40	3342-3349	methods	_	_	
15-41	3350-3353	for	_	_	
15-42	3354-3366	synthesizing	_	_	
15-43	3367-3375	polymers	_	_	
15-44	3375-3376	,	_	_	
15-45	3377-3381	such	_	_	
15-46	3382-3384	as	_	_	
15-47	3385-3397	polypeptides	_	_	
15-48	3397-3398	,	_	_	
15-49	3399-3413	peptide-linked	_	_	
15-50	3414-3423	compounds	_	_	
15-51	3423-3424	,	_	_	
15-52	3425-3428	etc	_	_	
15-53	3428-3429	.	_	_	
15-54	3429-3430	,	_	_	
15-55	3431-3434	may	_	_	
15-56	3435-3442	involve	_	_	
15-57	3443-3446	two	_	_	
15-58	3447-3452	basic	_	_	
15-59	3453-3462	reactions	_	_	
15-60	3462-3463	:	_	_	
15-61	3464-3465	(	_	_	
15-62	3465-3466	1	_	_	
15-63	3466-3467	)	_	_	
15-64	3468-3477	formation	_	_	
15-65	3478-3480	of	_	_	
15-66	3481-3484	one	_	_	
15-67	3485-3487	or	_	_	
15-68	3488-3492	more	_	_	
15-69	3493-3507	NCA-containing	_	_	
15-70	3508-3515	monomer	_	_	
15-71	3515-3516	(	_	_	
15-72	3516-3517	s	_	_	
15-73	3517-3518	)	_	_	
15-74	3519-3523	from	_	_	
15-75	3524-3527	one	_	_	
15-76	3528-3530	or	_	_	
15-77	3531-3535	more	_	_	
15-78	3536-3541	types	_	_	
15-79	3542-3544	of	_	_	
15-80	3545-3552	monomer	_	_	
15-81	3552-3553	(	_	_	
15-82	3553-3554	s	_	_	
15-83	3554-3555	)	_	_	
15-84	3555-3556	,	_	_	
15-85	3557-3560	and	_	_	
15-86	3561-3562	(	_	_	
15-87	3562-3563	2	_	_	
15-88	3563-3564	)	_	_	
15-89	3565-3579	polymerization	_	_	
15-90	3580-3582	of	_	_	
15-91	3583-3588	these	_	_	
15-92	3589-3596	monomer	_	_	
15-93	3596-3597	(	_	_	
15-94	3597-3598	s	_	_	
15-95	3598-3599	)	_	_	
15-96	3600-3602	to	_	_	
15-97	3603-3607	form	_	_	
15-98	3608-3609	a	_	_	
15-99	3610-3617	desired	_	_	
15-100	3618-3625	polymer	_	_	
15-101	3626-3633	product	_	_	
15-102	3633-3634	(	_	_	
15-103	3634-3635	s	_	_	
15-104	3635-3636	)	_	_	
15-105	3637-3641	upon	_	_	
15-106	3642-3654	introduction	_	_	
15-107	3655-3657	of	_	_	
15-108	3658-3660	at	_	_	
15-109	3661-3666	least	_	_	
15-110	3667-3670	one	_	_	
15-111	3671-3675	type	_	_	
15-112	3676-3678	of	_	_	
15-113	3679-3688	initiator	_	_	
15-114	3688-3689	.	_	_	

#Text=In the first reaction, NCA-containing monomer(s), which may include NCA-compounds and NCA-amino acids, may be formed by reacting one or more monomer(s) with a phosgene compound in an aprotic solvent to form a temporary N-chlorocarbonyl intermediate, which then cyclizes to form an NCA moiety of the NCA-containing monomer(s) with release of two HCl molecules (See, e.g., Example 1).
#Text=[0042] NCA-containing monomer(s) synthesized during the first reaction step may then be used in an NCA-based polymerization reaction to form a polymer, such as a polypeptide, peptide-linked compound, etc., which is initiated by the introduction of an initiator.
16-1	3690-3692	In	_	_	
16-2	3693-3696	the	_	_	
16-3	3697-3702	first	_	_	
16-4	3703-3711	reaction	_	_	
16-5	3711-3712	,	_	_	
16-6	3713-3727	NCA-containing	_	_	
16-7	3728-3735	monomer	_	_	
16-8	3735-3736	(	_	_	
16-9	3736-3737	s	_	_	
16-10	3737-3738	)	_	_	
16-11	3738-3739	,	_	_	
16-12	3740-3745	which	_	_	
16-13	3746-3749	may	_	_	
16-14	3750-3757	include	_	_	
16-15	3758-3771	NCA-compounds	_	_	
16-16	3772-3775	and	_	_	
16-17	3776-3785	NCA-amino	_	_	
16-18	3786-3791	acids	_	_	
16-19	3791-3792	,	_	_	
16-20	3793-3796	may	_	_	
16-21	3797-3799	be	_	_	
16-22	3800-3806	formed	_	_	
16-23	3807-3809	by	_	_	
16-24	3810-3818	reacting	_	_	
16-25	3819-3822	one	_	_	
16-26	3823-3825	or	_	_	
16-27	3826-3830	more	_	_	
16-28	3831-3838	monomer	_	_	
16-29	3838-3839	(	_	_	
16-30	3839-3840	s	_	_	
16-31	3840-3841	)	_	_	
16-32	3842-3846	with	_	_	
16-33	3847-3848	a	_	_	
16-34	3849-3857	phosgene	_	_	
16-35	3858-3866	compound	_	_	
16-36	3867-3869	in	_	_	
16-37	3870-3872	an	_	_	
16-38	3873-3880	aprotic	_	_	
16-39	3881-3888	solvent	_	_	
16-40	3889-3891	to	_	_	
16-41	3892-3896	form	_	_	
16-42	3897-3898	a	_	_	
16-43	3899-3908	temporary	_	_	
16-44	3909-3925	N-chlorocarbonyl	_	_	
16-45	3926-3938	intermediate	_	_	
16-46	3938-3939	,	_	_	
16-47	3940-3945	which	_	_	
16-48	3946-3950	then	_	_	
16-49	3951-3959	cyclizes	_	_	
16-50	3960-3962	to	_	_	
16-51	3963-3967	form	_	_	
16-52	3968-3970	an	_	_	
16-53	3971-3974	NCA	_	_	
16-54	3975-3981	moiety	_	_	
16-55	3982-3984	of	_	_	
16-56	3985-3988	the	_	_	
16-57	3989-4003	NCA-containing	_	_	
16-58	4004-4011	monomer	_	_	
16-59	4011-4012	(	_	_	
16-60	4012-4013	s	_	_	
16-61	4013-4014	)	_	_	
16-62	4015-4019	with	_	_	
16-63	4020-4027	release	_	_	
16-64	4028-4030	of	_	_	
16-65	4031-4034	two	_	_	
16-66	4035-4038	HCl	_	_	
16-67	4039-4048	molecules	_	_	
16-68	4049-4050	(	_	_	
16-69	4050-4053	See	_	_	
16-70	4053-4054	,	_	_	
16-71	4055-4058	e.g	_	_	
16-72	4058-4059	.	_	_	
16-73	4059-4060	,	_	_	
16-74	4061-4068	Example	_	_	
16-75	4069-4070	1	_	_	
16-76	4070-4071	)	_	_	
16-77	4071-4072	.	_	_	
16-78	4073-4074	[	_	_	
16-79	4074-4078	0042	_	_	
16-80	4078-4079	]	_	_	
16-81	4080-4094	NCA-containing	_	_	
16-82	4095-4102	monomer	_	_	
16-83	4102-4103	(	_	_	
16-84	4103-4104	s	_	_	
16-85	4104-4105	)	_	_	
16-86	4106-4117	synthesized	_	_	
16-87	4118-4124	during	_	_	
16-88	4125-4128	the	_	_	
16-89	4129-4134	first	_	_	
16-90	4135-4143	reaction	_	_	
16-91	4144-4148	step	_	_	
16-92	4149-4152	may	_	_	
16-93	4153-4157	then	_	_	
16-94	4158-4160	be	_	_	
16-95	4161-4165	used	_	_	
16-96	4166-4168	in	_	_	
16-97	4169-4171	an	_	_	
16-98	4172-4181	NCA-based	_	_	
16-99	4182-4196	polymerization	_	_	
16-100	4197-4205	reaction	_	_	
16-101	4206-4208	to	_	_	
16-102	4209-4213	form	_	_	
16-103	4214-4215	a	_	_	
16-104	4216-4223	polymer	_	_	
16-105	4223-4224	,	_	_	
16-106	4225-4229	such	_	_	
16-107	4230-4232	as	_	_	
16-108	4233-4234	a	_	_	
16-109	4235-4246	polypeptide	_	_	
16-110	4246-4247	,	_	_	
16-111	4248-4262	peptide-linked	_	_	
16-112	4263-4271	compound	_	_	
16-113	4271-4272	,	_	_	
16-114	4273-4276	etc	_	_	
16-115	4276-4277	.	_	_	
16-116	4277-4278	,	_	_	
16-117	4279-4284	which	_	_	
16-118	4285-4287	is	_	_	
16-119	4288-4297	initiated	_	_	
16-120	4298-4300	by	_	_	
16-121	4301-4304	the	_	_	
16-122	4305-4317	introduction	_	_	
16-123	4318-4320	of	_	_	
16-124	4321-4323	an	_	_	
16-125	4324-4333	initiator	_	_	
16-126	4333-4334	.	_	_	

#Text=Because both the amino group and carboxyl group on the .alpha.
17-1	4335-4342	Because	_	_	
17-2	4343-4347	both	_	_	
17-3	4348-4351	the	_	_	
17-4	4352-4357	amino	_	_	
17-5	4358-4363	group	_	_	
17-6	4364-4367	and	_	_	
17-7	4368-4376	carboxyl	_	_	
17-8	4377-4382	group	_	_	
17-9	4383-4385	on	_	_	
17-10	4386-4389	the	_	_	
17-11	4390-4391	.	_	_	
17-12	4391-4396	alpha	_	_	
17-13	4396-4397	.	_	_	

#Text=-carbon of a monomer form part of the cyclized ring structure of the NCA moiety of an NCA-containing monomer, the .alpha.
18-1	4397-4398	-	_	_	
18-2	4398-4404	carbon	_	_	
18-3	4405-4407	of	_	_	
18-4	4408-4409	a	_	_	
18-5	4410-4417	monomer	_	_	
18-6	4418-4422	form	_	_	
18-7	4423-4427	part	_	_	
18-8	4428-4430	of	_	_	
18-9	4431-4434	the	_	_	
18-10	4435-4443	cyclized	_	_	
18-11	4444-4448	ring	_	_	
18-12	4449-4458	structure	_	_	
18-13	4459-4461	of	_	_	
18-14	4462-4465	the	_	_	
18-15	4466-4469	NCA	_	_	
18-16	4470-4476	moiety	_	_	
18-17	4477-4479	of	_	_	
18-18	4480-4482	an	_	_	
18-19	4483-4497	NCA-containing	_	_	
18-20	4498-4505	monomer	_	_	
18-21	4505-4506	,	_	_	
18-22	4507-4510	the	_	_	
18-23	4511-4512	.	_	_	
18-24	4512-4517	alpha	_	_	
18-25	4517-4518	.	_	_	

#Text=-amino group of an NCA-containing monomer is not available to function as an initiating group until the NCA ring structure (i.e., NCA moiety) of the NCA-containing monomer is opened to reform the .alpha.
19-1	4518-4519	-	_	_	
19-2	4519-4524	amino	_	_	
19-3	4525-4530	group	_	_	
19-4	4531-4533	of	_	_	
19-5	4534-4536	an	_	_	
19-6	4537-4551	NCA-containing	_	_	
19-7	4552-4559	monomer	_	_	
19-8	4560-4562	is	_	_	
19-9	4563-4566	not	_	_	
19-10	4567-4576	available	_	_	
19-11	4577-4579	to	_	_	
19-12	4580-4588	function	_	_	
19-13	4589-4591	as	_	_	
19-14	4592-4594	an	_	_	
19-15	4595-4605	initiating	_	_	
19-16	4606-4611	group	_	_	
19-17	4612-4617	until	_	_	
19-18	4618-4621	the	_	_	
19-19	4622-4625	NCA	_	_	
19-20	4626-4630	ring	_	_	
19-21	4631-4640	structure	_	_	
19-22	4641-4642	(	_	_	
19-23	4642-4645	i.e	_	_	
19-24	4645-4646	.	_	_	
19-25	4646-4647	,	_	_	
19-26	4648-4651	NCA	_	_	
19-27	4652-4658	moiety	_	_	
19-28	4658-4659	)	_	_	
19-29	4660-4662	of	_	_	
19-30	4663-4666	the	_	_	
19-31	4667-4681	NCA-containing	_	_	
19-32	4682-4689	monomer	_	_	
19-33	4690-4692	is	_	_	
19-34	4693-4699	opened	_	_	
19-35	4700-4702	to	_	_	
19-36	4703-4709	reform	_	_	
19-37	4710-4713	the	_	_	
19-38	4714-4715	.	_	_	
19-39	4715-4720	alpha	_	_	
19-40	4720-4721	.	_	_	

#Text=-amino group of its base monomer.
20-1	4721-4722	-	_	_	
20-2	4722-4727	amino	_	_	
20-3	4728-4733	group	_	_	
20-4	4734-4736	of	_	_	
20-5	4737-4740	its	_	_	
20-6	4741-4745	base	_	_	
20-7	4746-4753	monomer	_	_	
20-8	4753-4754	.	_	_	

#Text=Therefore, the NCA-based polymerization reaction may not begin until an initiator is introduced to open the NCA-ring structure (or NCA moiety) by forming a peptide bond between the .alpha.
21-1	4755-4764	Therefore	_	_	
21-2	4764-4765	,	_	_	
21-3	4766-4769	the	_	_	
21-4	4770-4779	NCA-based	_	_	
21-5	4780-4794	polymerization	_	_	
21-6	4795-4803	reaction	_	_	
21-7	4804-4807	may	_	_	
21-8	4808-4811	not	_	_	
21-9	4812-4817	begin	_	_	
21-10	4818-4823	until	_	_	
21-11	4824-4826	an	_	_	
21-12	4827-4836	initiator	_	_	
21-13	4837-4839	is	_	_	
21-14	4840-4850	introduced	_	_	
21-15	4851-4853	to	_	_	
21-16	4854-4858	open	_	_	
21-17	4859-4862	the	_	_	
21-18	4863-4871	NCA-ring	_	_	
21-19	4872-4881	structure	_	_	
21-20	4882-4883	(	_	_	
21-21	4883-4885	or	_	_	
21-22	4886-4889	NCA	_	_	
21-23	4890-4896	moiety	_	_	
21-24	4896-4897	)	_	_	
21-25	4898-4900	by	_	_	
21-26	4901-4908	forming	_	_	
21-27	4909-4910	a	_	_	
21-28	4911-4918	peptide	_	_	
21-29	4919-4923	bond	_	_	
21-30	4924-4931	between	_	_	
21-31	4932-4935	the	_	_	
21-32	4936-4937	.	_	_	
21-33	4937-4942	alpha	_	_	
21-34	4942-4943	.	_	_	

#Text=-carbonyl group of the NCA-containing monomer and the initiating group of an initiator, with the release of carbon dioxide (CO.sub.2) as a by-product.
22-1	4943-4944	-	_	_	
22-2	4944-4952	carbonyl	_	_	
22-3	4953-4958	group	_	_	
22-4	4959-4961	of	_	_	
22-5	4962-4965	the	_	_	
22-6	4966-4980	NCA-containing	_	_	
22-7	4981-4988	monomer	_	_	
22-8	4989-4992	and	_	_	
22-9	4993-4996	the	_	_	
22-10	4997-5007	initiating	_	_	
22-11	5008-5013	group	_	_	
22-12	5014-5016	of	_	_	
22-13	5017-5019	an	_	_	
22-14	5020-5029	initiator	_	_	
22-15	5029-5030	,	_	_	
22-16	5031-5035	with	_	_	
22-17	5036-5039	the	_	_	
22-18	5040-5047	release	_	_	
22-19	5048-5050	of	_	_	
22-20	5051-5057	carbon	_	_	
22-21	5058-5065	dioxide	_	_	
22-22	5066-5067	(	_	_	
22-23	5067-5073	CO.sub	_	_	
22-24	5073-5075	.2	_	_	
22-25	5075-5076	)	_	_	
22-26	5077-5079	as	_	_	
22-27	5080-5081	a	_	_	
22-28	5082-5092	by-product	_	_	
22-29	5092-5093	.	_	_	

#Text=As a result of opening the ring structure of the NCA moiety of an NCA-containing monomer during an NCA-based polymerization reaction, the .alpha.
23-1	5094-5096	As	_	_	
23-2	5097-5098	a	_	_	
23-3	5099-5105	result	_	_	
23-4	5106-5108	of	_	_	
23-5	5109-5116	opening	_	_	
23-6	5117-5120	the	_	_	
23-7	5121-5125	ring	_	_	
23-8	5126-5135	structure	_	_	
23-9	5136-5138	of	_	_	
23-10	5139-5142	the	_	_	
23-11	5143-5146	NCA	_	_	
23-12	5147-5153	moiety	_	_	
23-13	5154-5156	of	_	_	
23-14	5157-5159	an	_	_	
23-15	5160-5174	NCA-containing	_	_	
23-16	5175-5182	monomer	_	_	
23-17	5183-5189	during	_	_	
23-18	5190-5192	an	_	_	
23-19	5193-5202	NCA-based	_	_	
23-20	5203-5217	polymerization	_	_	
23-21	5218-5226	reaction	_	_	
23-22	5226-5227	,	_	_	
23-23	5228-5231	the	_	_	
23-24	5232-5233	.	_	_	
23-25	5233-5238	alpha	_	_	
23-26	5238-5239	.	_	_	

#Text=-amino group of the base monomer of the NCA-containing monomer is reformed and able to function as an "initiating group" for another NCA-containing monomer (i.e., for the next round of polymerization).
24-1	5239-5240	-	_	_	
24-2	5240-5245	amino	_	_	
24-3	5246-5251	group	_	_	
24-4	5252-5254	of	_	_	
24-5	5255-5258	the	_	_	
24-6	5259-5263	base	_	_	
24-7	5264-5271	monomer	_	_	
24-8	5272-5274	of	_	_	
24-9	5275-5278	the	_	_	
24-10	5279-5293	NCA-containing	_	_	
24-11	5294-5301	monomer	_	_	
24-12	5302-5304	is	_	_	
24-13	5305-5313	reformed	_	_	
24-14	5314-5317	and	_	_	
24-15	5318-5322	able	_	_	
24-16	5323-5325	to	_	_	
24-17	5326-5334	function	_	_	
24-18	5335-5337	as	_	_	
24-19	5338-5340	an	_	_	
24-20	5341-5342	"	_	_	
24-21	5342-5352	initiating	_	_	
24-22	5353-5358	group	_	_	
24-23	5358-5359	"	_	_	
24-24	5360-5363	for	_	_	
24-25	5364-5371	another	_	_	
24-26	5372-5386	NCA-containing	_	_	
24-27	5387-5394	monomer	_	_	
24-28	5395-5396	(	_	_	
24-29	5396-5399	i.e	_	_	
24-30	5399-5400	.	_	_	
24-31	5400-5401	,	_	_	
24-32	5402-5405	for	_	_	
24-33	5406-5409	the	_	_	
24-34	5410-5414	next	_	_	
24-35	5415-5420	round	_	_	
24-36	5421-5423	of	_	_	
24-37	5424-5438	polymerization	_	_	
24-38	5438-5439	)	_	_	
24-39	5439-5440	.	_	_	

#Text=Through this iterative process within a reaction mixture, the NCA-based polymerization reaction may occur spontaneously, and a polymer, such as a polypeptide, peptide-linked compound, etc., may be formed.
25-1	5441-5448	Through	_	_	
25-2	5449-5453	this	_	_	
25-3	5454-5463	iterative	_	_	
25-4	5464-5471	process	_	_	
25-5	5472-5478	within	_	_	
25-6	5479-5480	a	_	_	
25-7	5481-5489	reaction	_	_	
25-8	5490-5497	mixture	_	_	
25-9	5497-5498	,	_	_	
25-10	5499-5502	the	_	_	
25-11	5503-5512	NCA-based	_	_	
25-12	5513-5527	polymerization	_	_	
25-13	5528-5536	reaction	_	_	
25-14	5537-5540	may	_	_	
25-15	5541-5546	occur	_	_	
25-16	5547-5560	spontaneously	_	_	
25-17	5560-5561	,	_	_	
25-18	5562-5565	and	_	_	
25-19	5566-5567	a	_	_	
25-20	5568-5575	polymer	_	_	
25-21	5575-5576	,	_	_	
25-22	5577-5581	such	_	_	
25-23	5582-5584	as	_	_	
25-24	5585-5586	a	_	_	
25-25	5587-5598	polypeptide	_	_	
25-26	5598-5599	,	_	_	
25-27	5600-5614	peptide-linked	_	_	
25-28	5615-5623	compound	_	_	
25-29	5623-5624	,	_	_	
25-30	5625-5628	etc	_	_	
25-31	5628-5629	.	_	_	
25-32	5629-5630	,	_	_	
25-33	5631-5634	may	_	_	
25-34	5635-5637	be	_	_	
25-35	5638-5644	formed	_	_	
25-36	5644-5645	.	_	_	

#Text=Such NCA-based polymerization reaction may occur through either protic or aprotic mechanisms.
26-1	5646-5650	Such	_	_	
26-2	5651-5660	NCA-based	_	_	
26-3	5661-5675	polymerization	_	_	
26-4	5676-5684	reaction	_	_	
26-5	5685-5688	may	_	_	
26-6	5689-5694	occur	_	_	
26-7	5695-5702	through	_	_	
26-8	5703-5709	either	_	_	
26-9	5710-5716	protic	_	_	
26-10	5717-5719	or	_	_	
26-11	5720-5727	aprotic	_	_	
26-12	5728-5738	mechanisms	_	_	
26-13	5738-5739	.	_	_	

#Text=See, e.g., Block, H., "Poly(Gamma-Benzyl-L-Glutamate) and other Glutamic Acid Containing Polymers," Vol. 9., Ed.
27-1	5740-5743	See	_	_	
27-2	5743-5744	,	_	_	
27-3	5745-5748	e.g	_	_	
27-4	5748-5749	.	_	_	
27-5	5749-5750	,	_	_	
27-6	5751-5756	Block	_	_	
27-7	5756-5757	,	_	_	
27-8	5758-5759	H	_	_	
27-9	5759-5760	.	_	_	
27-10	5760-5761	,	_	_	
27-11	5762-5763	"	_	_	
27-12	5763-5767	Poly	_	_	
27-13	5767-5768	(	_	_	
27-14	5768-5792	Gamma-Benzyl-L-Glutamate	_	_	
27-15	5792-5793	)	_	_	
27-16	5794-5797	and	_	_	
27-17	5798-5803	other	_	_	
27-18	5804-5812	Glutamic	_	_	
27-19	5813-5817	Acid	_	_	
27-20	5818-5828	Containing	_	_	
27-21	5829-5837	Polymers	_	_	
27-22	5837-5838	,	_	_	
27-23	5838-5839	"	_	_	
27-24	5840-5843	Vol	_	_	
27-25	5843-5844	.	_	_	
27-26	5845-5846	9	_	_	
27-27	5846-5847	.	_	_	
27-28	5847-5848	,	_	_	
27-29	5849-5851	Ed	_	_	
27-30	5851-5852	.	_	_	

#Text=M.
28-1	5853-5854	M	_	_	
28-2	5854-5855	.	_	_	

#Text=B.
29-1	5856-5857	B	_	_	
29-2	5857-5858	.	_	_	

#Text=Huglin, (Gordon and Breach Science Publishers, New York, 1983), the entire contents and disclosure of which is hereby incorporated by reference.
30-1	5859-5865	Huglin	_	_	
30-2	5865-5866	,	_	_	
30-3	5867-5868	(	_	_	
30-4	5868-5874	Gordon	_	_	
30-5	5875-5878	and	_	_	
30-6	5879-5885	Breach	_	_	
30-7	5886-5893	Science	_	_	
30-8	5894-5904	Publishers	_	_	
30-9	5904-5905	,	_	_	
30-10	5906-5909	New	_	_	
30-11	5910-5914	York	_	_	
30-12	5914-5915	,	_	_	
30-13	5916-5920	1983	_	_	
30-14	5920-5921	)	_	_	
30-15	5921-5922	,	_	_	
30-16	5923-5926	the	_	_	
30-17	5927-5933	entire	_	_	
30-18	5934-5942	contents	_	_	
30-19	5943-5946	and	_	_	
30-20	5947-5957	disclosure	_	_	
30-21	5958-5960	of	_	_	
30-22	5961-5966	which	_	_	
30-23	5967-5969	is	_	_	
30-24	5970-5976	hereby	_	_	
30-25	5977-5989	incorporated	_	_	
30-26	5990-5992	by	_	_	
30-27	5993-6002	reference	_	_	
30-28	6002-6003	.	_	_	
